发明名称 Pentadieneamides
摘要 Compounds of the formula <IMAGE> I Y is O ir S, *A is paraphenylene or *--(CH2)n--(X)m-(CH2)r--, X is O, S or -CH=CH-, n or r, independently, are integers from 0 to 3, s is an integer from 0 to 1, m is an integer from 0 to 1, provided that when m is 1, n+s must be at least 2, R1 and R2, independently, are hydrogen, lower alkyl, cycloalkyl, lower alkenyl, Het, aryl, R3, R4 and R8, independently, are hydrogen, lower alkyl, aryl, R5 and R6, independently, are hydrogen or lower alkyl, R7 is hydrogen, lower alkyl, cycloalkyl, Het-lower alkyl or aryl, Het is a monocyclic 5- or 6-membered hetero aromatic or a bicyclic heteroaromatic radical containing one or two hetero atoms selected from nitrogen, oxygen and sulfur, which radical may be substituted by lower alkyl, halogen or aryl, and the asterisk denotes the point of attachment, and when R6 and R7 are different, their enantiomers and racemic mixtures thereof, when R1 and R2 are different, their geometric isomers, and pharmaceutically acceptable acid addition salts thereof, are described. The compounds of formula I exhibit activity as platelet activating factor (PAF) antagonists and are, therefore, useful in disease states characerized by excess platelet activating factor or for the prevention and treatment of cardiovascular disease, pulmonary diseases, immunological disorders, inflammatory diseases, dermatological disorders, shock or transplant rejection.
申请公布号 US4788206(A) 申请公布日期 1988.11.29
申请号 US19870072389 申请日期 1987.07.10
申请人 HOFFMANN-LA ROCHE INC. 发明人 GUTHRIE, ROBERT W.;KIERSTEAD, RICHARD W.;TILLEY, JEFFERSON W.
分类号 C07D213/38;A61K31/16;A61K31/34;A61K31/35;A61K31/38;A61K31/40;A61K31/415;A61K31/42;A61K31/425;A61K31/435;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/47;A61K31/472;A61K31/495;A61K31/535;A61K31/54;A61P7/02;C07C233/38;C07D207/335;C07D213/40;C07D213/56;C07D217/02;C07D217/14;C07D217/16;C07D227/00;C07D247/00;C07D269/00;C07D283/00;C07D409/12;C07D521/00;(IPC1-7):C07D213/00 主分类号 C07D213/38
代理机构 代理人
主权项
地址